PE
IRMD icon

Point72 Europe’s iRadimed IRMD Stock Holding History

Point72 Europe’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$894 Buy
+13
New +$866 ﹤0.01% 695

Other funds holding IRMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Point72 Europe's IRMD Position: Q3 2025 in Review

Point72 Europe opened a new position in iRadimed (IRMD) in Q3 2025: 13 shares worth $894. The stake represents ﹤0.01% of the portfolio and ranks #695 among its holdings.

185 funds tracked by Wall St. Rank hold IRMD as of Q3 2025.

  • Point72 Europe held 13 shares of iRadimed worth $894 as of Q3 2025.
  • iRadimed was a new Point72 Europe position in Q3 2025.
  • iRadimed made up ﹤0.01% of Point72 Europe's portfolio in Q3 2025, its #695 holding.
  • 185 funds tracked by Wall St. Rank held iRadimed as of Q3 2025.

Based on Point72 Europe's 13F filing for Q3 2025, filed 14 Nov 2025.